INmune Bio
INMB
INMB
81 hedge funds and large institutions have $48.1M invested in INmune Bio in 2025 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 25 increasing their positions, 22 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
14% more repeat investments, than reductions
Existing positions increased: 25 | Existing positions reduced: 22
13% more funds holding
Funds holding: 72 → 81 (+9)
1.65% less ownership
Funds ownership: 28.53% → 26.88% (-1.7%)
Holders
81
Holding in Top 10
2
Calls
$3.07M
Puts
$1.54M
Top Buyers
| 1 | +$690K | |
| 2 | +$625K | |
| 3 | +$420K | |
| 4 |
PP
Praetorian PR
Rincon,
Puerto Rico
|
+$412K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$385K |
Top Sellers
| 1 | -$868K | |
| 2 | -$730K | |
| 3 | -$561K | |
| 4 |
Morgan Stanley
New York
|
-$552K |
| 5 |
DIG
Dauntless Investment Group
Etna,
New Hampshire
|
-$478K |
